| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | 0.26 | 0.1 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |